Signalling the resistance of the robotic process automation market despite a poorly performing economy, RPA solutions provider Blue Prism announced that it has raised over $124 million in equity financing at a valuation of around $1.24 billion. According to CEO Jason Kingdon, a bulk of the capital will go into bolstering the company's automation suite. Just last month, Blue Prism had launched a COVID-19 response task team to perform a variety of functions. This team has been working with the UK's National Health Service, University of California, and the Leeds Building Society to automate personnel, vaccine development, finance, and related health care support functions. "Our RPA solution is more important than ever in this environment," Kingdon said in a report. "The impact of this pandemic is unknown, and as a result, we are taking action to invest and reinforce our product differentiation in preparation for the opportunities that will occur," he added.